Advertisement

Topics

Glucose 5% Intravenous Infusion in VIAFLEX Container | Glucose [Baxter Healthcare Corporation] | BioPortfolio

12:29 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Baxter LogoAHB0086A

Baxter and Viaflex are Registered Trademarks ofBaxter International Inc Baxter Healthcare Pty Ltd1 Baxter Drive Old Toongabbie NSW Australia

VIAFLEX 88-25-01-068E Store below 30ºC Do Not FreezeSterile NonPyrogenic AUST R 19503

AUSTRALIAN MADE Symbol

Use as directed by a physicianUse in one patient on one occasion onlyContains no antimicrobial preservative

Each 50 mL contains - Anhydrous Glucose 2.5 g- Water for Injections QSpH Range 3.5 – 6.5

Approx Millimoles per 50 mL - Glucose 14Approx Kilojoules per 50 mL 42 kJApprox Osmolality 278 mOsm/kg

ISOTONIC

50 mL Intravenous Infusion

Glucose 5%

F

Bar Code0 085412 311388

_25

Baxter LogoAHB0087

Baxter and Viaflex are Registered Trademarks ofBaxter International Inc Baxter Healthcare Pty Ltd1 Baxter Drive Old Toongabbie NSW Australia

VIAFLEX 88-25-01-069F Store below 30ºC Do Not FreezeSterile NonPyrogenic AUST R 48525

AUSTRALIAN MADE Symbol

Use as directed by a physicianUse in one patient on one occasion onlyContains no antimicrobial preservative

Each 100 mL contains - Anhydrous Glucose 5 g- Water for Injections QSpH Range 3.5 – 6.5

Approx Millimoles per 100 mL - Glucose 28Approx Kilojoules per 100 mL 84 kJApprox Osmolality 278 mOsm/kg

ISOTONIC

100 mL Intravenous Infusion

Glucose 5%

B

Bar Code9 318242 000506

_25

_50

_75

Manufacturer

Baxter Healthcare Corporation

Active Ingredients

Source

Clinical Trials [2709 Associated Clinical Trials listed on BioPortfolio]

The Effects of Glucose Monitor on Patients With Diabetes

To assess the effect of glucose monitors on glucose control and cardiovascular risks.

Oral Glucose Solution as Pain Relief in Newborns: Results of a Clinical Trial

This study investigates which concentration of glucose is most effective in reducing pain for venipuncture in the newborn.

Glucose Tolerance in Children With Cystic Fibrosis

The aim is to describe the association of glucose tolerance measured with three different tools (continuous glucose measurement system - CGMS, oral glucose tolerance testing - OGTT and opt...

Non-invasive Glucose Measurement Using Laser Technology

This study is to evaluate the capability of Raman spectroscopy as a non-invasive method for monitoring concentrations of glucose by illuminating a small spot on the skin, collecting and an...

Glucose Control In Hematopoetic Stem Cell Transplant

To determine whether intensive glucose control results in improved mortality and reduced hospital stay length by performing a randomized trial of intensive glucose management (blood glucos...

PubMed Articles [2836 Associated PubMed Articles listed on BioPortfolio]

Glucose-Mediated Glucose Disposal at Baseline Insulin is Impaired in IFG.

To quantitate glucose-mediated glucose disposal with and without basal insulin replacement and insulin-mediated glucose disposal in impaired fasting glucose (IFG) subjects.

C-glucose breath tests: a non-invasive method for detecting early clinical manifestations of exogenous glucose metabolism in type 2 diabetic patients.

C-glucose breath tests are reported as an alternative non-invasive method to evaluate glucose metabolism. However, the metabolic results differ based on the site of the carbon atom in the glucose. The...

Neuroenergetics: Astrocytes Have a Sweet Spot for Glucose.

Astrocytes are polarized cells that are known to take up glucose while delivering lactate, not glucose, for neuronal use. A new study suggests how astrocytes could facilitate glucose uptake, storage a...

Glucose, fructosamine, and insulin measurements in saliva of dogs: variations after an experimental glucose administration.

The aim of this study was to evaluate if glucose, fructosamine, and insulin levels can be measured in saliva of dogs and assess the changes in these compounds after an experimental glucose administrat...

Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study.

Animal studies suggest sphingolipids as an early marker of impaired glucose metabolism; however, research in humans is limited. We evaluated whether individual sphingolipid species were associated wit...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record